Video

Q&A With Brian Kestenbaum From University of Washington: Fibroblast Growth Factor 23 May Play Key Role in Future Disease Treatment

Author(s):

While everyone has the fibroblast 23 hormone there has been some research into whether it can be linked to diseases and other conditions that can make some people sick.

While everyone has the fibroblast growth factor 23 hormone there has been some research into whether it can be linked to diseases and other conditions that can make some people sick.

Brian Kestenbaum, MD, MS, from the University of Washington discussed some of the early research on the hormone during the AACE's 24th Annual Scientific and Clinical Congress. Kestenbaum said the main role appears to be helping kidneys clear phosphates from the body. The question being investigated is whether it is tied to other more serious conditions like kidney disease and what can be done to help those patients. Even as more is learned about the role of the hormone in the body Kestenbaum said there is nothing that can be done to reverse the negative effects it has on the body.

Related Videos
Pranav Garimella, MBBS, MPH | Credit: GlobalNewsWire
Caroline Piatek, MD: High HCRU, Patient Concerns Highlight Great Unmet Need in wAIHA
Steven W. Pipe, MD: Supporting Gene Therapy Implementation for Hemophilia
Corinna L. Schultz, MD: Improving Sickle Cell Trait Documentation in Infancy
Sibgha Zaheer, MD: Determining Washout Period With Fitusiran, Emicizumab Transition for Hemophilia
Pavan K. (Tem) Bendapudi, MD: Large-Scale Analyses Elucidate Genetic Risk of Thrombosis
Seema Rani, MD: Examining Sleep Health in Youth With SCD
Experts' Perspectives: Top Stories in Cardiology for 2024
Daniel Wang: A More Appropriate Ferritin Threshold is Cost-Effective for Iron Deficiency Screening
Kimberly A. Davidow, MD: Elucidating Risk of Autoimmune Disease in Childhood Cancer Survivors
© 2025 MJH Life Sciences

All rights reserved.